Organon & Co (OGN)

• Market cap: $2.22B
• 1 day: -0.7%
• 5 days: -12.32%
• 1 month: 19.78%
• 3 months: 29.98%
• 6 months: -14.94%
• Year to date: 17.96%
• 1 year: -46.52%
• 5 years: -74.32%
• 10 years: -74.32%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Employees: 10,000